{"schema_version":"1","generated_at":"2026-11-04T14:55:09.172Z","data_as_of":null,"url":"https://www.findmykol.com/kol/james-butrynski","json_url":"https://www.findmykol.com/kol/james-butrynski/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"james-butrynski","name":"James Butrynski","credential":"MD","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"Willamette Valley Cancer Institute and Research Center","institution_url":"https://www.findmykol.com/institution/willamette-valley-cancer-institute-and-research-center","city":"Eugene","state":"OR","region":{"label":"West","url":"https://www.findmykol.com/region/west"}},"identifiers":{"npi":"1427134287","openalex":"A5087253387"},"summary":"James Butrynski is an Oncology physician affiliated with Willamette Valley Cancer Institute and Research Center. OpenAlex indexes 65 publications with 4,906 citations (h-index 29); ClinicalTrials.gov lists 2 registered studies matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":65,"cited_by_count":4906,"h_index":29,"latest_activity_year":2024,"source":"works"},"trials":{"count":2,"shown":2,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT01189253","title":"Doxorubicin Hydrochloride or Trabectedin in Treating Patients With Previously Untreated Advanced or Metastatic Soft Tissue Sarcoma","phase":"PHASE2/PHASE3","status":"TERMINATED","role":"Overall official","sponsor":"European Organisation for Research and Treatment of Cancer - EORTC","source_url":"https://clinicaltrials.gov/study/NCT01189253","trial_url":"https://www.findmykol.com/trial/NCT01189253"},{"nct":"NCT00194766","title":"Continuous Temozolomide in Patients With Advanced or Metastatic Soft Tissue Sarcoma or Metastatic Breast Cancer","phase":"PHASE2","status":"COMPLETED","role":"Overall official","sponsor":"University of Washington","source_url":"https://clinicaltrials.gov/study/NCT00194766","trial_url":"https://www.findmykol.com/trial/NCT00194766"}],"source":"trials"},"payments":{"company_count":4,"program_years":{"first":2021,"last":null},"rows_total":33,"shown":3,"withheld":30,"rows":[{"payer":"Mirati Therapeutics","program_year":2025,"amount_usd":103150.3,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1427134287"},{"payer":"Eli Lilly","program_year":2025,"amount_usd":6316.65,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1427134287"},{"payer":"Merck & Co.","program_year":2025,"amount_usd":1024.42,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1427134287"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1427134287","source":"payments"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Efficacy and Safety of Sacituzumab Govitecan in Patients With Advanced Solid Tumors (TROPiCS-03): Analysis in Patients With Advanced Endometrial Cancer","year":2024,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.23.02767","status":"verified"},{"title":"Biomarker testing in early-stage NSCLC: Results from the MYLUNG Consortium.","year":2024,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2024.42.16_suppl.8047","status":"verified"},{"title":"Contemporary biomarker testing rates in both early and advanced NSCLC: Results from the MYLUNG pragmatic study.","year":2023,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2023.41.16_suppl.9109","status":"verified"},{"title":"TROPiCS-03: A phase 2 basket study of sacituzumab govitecan (SG) in patients (pts) with metastatic solid tumors—Early analysis in pts with advanced/metastatic endometrial cancer (EC).","year":2023,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2023.41.16_suppl.5610","status":"verified"},{"title":"Results of a Randomized, Double-Blinded, Placebo-Controlled, Phase 2.5 Study of Saracatinib (AZD0530), in Patients with Recurrent Osteosarcoma Localized to the Lung","year":2020,"journal":"Sarcoma","source_url":"https://doi.org/10.1155/2020/7935475","status":"verified"}],"source":"works"},"contact":{"address_1":"520 COUNTRY CLUB PKWY","city":"Eugene","state":"OR","zip":"974016043","phone":"541-683-5001","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1427134287","source":"identity"},"similar":[{"name":"Jeff Sharman","slug":"jeff-sharman","institution":"Willamette Valley Cancer Institute and Research Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/jeff-sharman","json_url":"https://www.findmykol.com/kol/jeff-sharman/profile.json"},{"name":"Merideth Wendland","slug":"merideth-wendland","institution":"Willamette Valley Cancer Institute and Research Center","specialty":"Radiation Oncology","url":"https://www.findmykol.com/kol/merideth-wendland","json_url":"https://www.findmykol.com/kol/merideth-wendland/profile.json"},{"name":"Christopher Yasenchak","slug":"christopher-yasenchak","institution":"Willamette Valley Cancer Institute and Research Center","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christopher-yasenchak","json_url":"https://www.findmykol.com/kol/christopher-yasenchak/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Beth Karlan","slug":"beth-karlan","institution":"University of California, Los Angeles","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/beth-karlan","json_url":"https://www.findmykol.com/kol/beth-karlan/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":30,"publications":45}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2017-05-04","collected_at":"2026-11-03T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"}},"methodology_url":"https://www.findmykol.com/about#methodology"}